Financhill
Back

Biomarin Pharmaceutical Vs. Merck & Industry Stock Comparison

Buy
60

BMRN
Biomarin Pharmaceutical

Last Price:
64.25
Seasonality Move:
12.47%
Sell
27

MRK
Merck &

Last Price:
99.13
Seasonality Move:
3.55%
Buy
60
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $63.45. The Score for BMRN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
27
Merck & (MRK) is a Sell

Is Merck & a Buy, Sell or Hold?

  • The current Merck & [MRK] share price is $99.86. The Score for MRK is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • MRK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $63.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.

MRK Stock Price Chart

What is Merck &'s stock price today?

  • The Merck & share price today is $99.86
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRK is experiencing buying pressure, which is a positive indicator for future bullish movement.

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.1 Sell
Relative Strength Index (14 RSI): 33.54 Sell
Chaikin Money Flow: 933432 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (64.12 - 69.52) Sell
Bollinger Bands (100): (68.19 - 87.29) Sell

MRK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.86 Sell
Relative Strength Index (14 RSI): 41.27 Sell
Chaikin Money Flow: 10140740 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (98.4 - 105.3) Sell
Bollinger Bands (100): (104.93 - 122.01) Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 63.96 Sell
20-day SMA: 65.96 Sell
50-day SMA: 68.96 Sell
200-day SMA: 81.18 Sell
8-day EMA: 63.79 Sell
20-day EMA: 65.7 Sell
50-day EMA: 69.97 Sell
200-day EMA: 79.54 Sell

MRK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 97.77 Buy
20-day SMA: 100.61 Sell
50-day SMA: 107.54 Sell
200-day SMA: 120.56 Sell
8-day EMA: 98.45 Buy
20-day EMA: 100.78 Sell
50-day EMA: 106.05 Sell
200-day EMA: 114.81 Sell

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.83 per share.

Merck & Earnings Growth & MRK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.98 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.36 per share, and an increase next year of $1.75 per share.

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Merck & Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):